Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

208
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
208
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

234
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
234
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

139
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
139
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Common Respiratory Disorders01:31

Common Respiratory Disorders

515
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
515
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

186
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development.

JCI insight·2026
Same author

AlveolEye: rapid and precise lung morphometry guided by computer vision.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Novel Ru(II)-photo-antibiotics for the development of infection-resistant mask coatings.

Chemical communications (Cambridge, England)·2025
Same author

AlveolEye: Rapid and precise lung morphometry guided by computer vision.

bioRxiv : the preprint server for biology·2025
Same author

Targeted RNA sequencing identified gene expression profiles linked to severe necrosis and mortality in preterm infants with surgical necrotizing enterocolitis.

Research square·2025
Same author

Ginger: A Nutraceutical Supplement for Protection Against Various Cardiovascular Diseases in Clinical Trials.

Cureus·2025
Same journal

Milk Fat Globules: 2024 Updates.

Newborn (Clarksville, Md.)·2024
Same journal

CMV-induced Hearing Loss.

Newborn (Clarksville, Md.)·2024
Same journal

Point-of-care Ultrasound to Diagnose and Monitor the Course of Necrotizing Enterocolitis.

Newborn (Clarksville, Md.)·2023
Same journal

Extrauterine Growth Restriction: Need for an Accurate Definition.

Newborn (Clarksville, Md.)·2023
Same journal

Clinical Correlates of Cholestasis in Preterm Infants with Surgical Necrotizing Enterocolitis.

Newborn (Clarksville, Md.)·2023
Same journal

Linked Th17 and Calgranulin Responses in Maternal-cord Blood Dyads of Preterm Gestations with Histologic Chorioamnionitis.

Newborn (Clarksville, Md.)·2023
See all related articles

Related Experiment Video

Updated: Jul 3, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Respiratory Syncytial Virus Infections in Neonates: A Persisting Problem.

Srijan Singh1,2, Akhil Maheshwari2,3, Ilhama Namazova2,4

  • 1Neonatologist, Kailash Hospital, Noida, Uttar Pradesh, India.

Newborn (Clarksville, Md.)
|February 13, 2024
PubMed
Summary
This summary is machine-generated.

Respiratory syncytial virus (RSV) causes significant infant respiratory infections and deaths globally. Early diagnosis via RT-PCR and supportive care are crucial for managing RSV, with hygiene as a key preventive measure.

Keywords:
ArexvyBronchiolitisLower respiratory tract infectionNeonateNerve growth factor/TrkA receptor axisNewbornNirsevimabPalivizumabPerinatal RSV infectionPneumoviridae

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.7K

Related Experiment Videos

Last Updated: Jul 3, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.7K

Area of Science:

  • Virology
  • Pediatrics
  • Infectious Diseases

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants globally.
  • RSV accounts for 2.3% of neonatal deaths and commonly affects children under 24 months.
  • Infection can lead to severe outcomes like wheezing, hospitalization, and long-term asthma.

Purpose of the Study:

  • To summarize the epidemiology, diagnosis, and management of respiratory syncytial virus infections in infants.
  • To highlight the importance of diagnostic methods and preventive strategies for RSV.
  • To discuss current recommendations regarding prophylaxis and long-term sequelae.

Main Methods:

  • Literature review of RSV epidemiology, clinical presentation, and diagnostic techniques.
  • Analysis of current therapeutic and preventive guidelines for RSV infection.
  • Examination of recent recommendations on RSV prophylaxis for high-risk infants.

Main Results:

  • Reverse transcriptase polymerase chain reaction (RT-PCR) offers rapid and sensitive RSV detection.
  • Supportive care, hygiene, and isolation are primary management strategies.
  • Prophylaxis recommendations have been updated, with limitations for certain preterm infants.

Conclusions:

  • RSV poses a substantial global health burden on young children.
  • Accurate diagnosis and effective preventive measures are essential for controlling RSV.
  • Long-term health issues and healthcare costs associated with RSV necessitate ongoing research and public health efforts.